FABP5 Overview
Molecule Name
Fatty acid binding protein 5
Synonyms
FABP5,E-FABP,PA-FABP
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
Fatty Acid Binding Protein 5，PA-FABP，E-FABP，Psoriasis-Associated Fatty Acid-Binding Protein Homolog，Fatty Acid Binding Protein 5 (Psoriasis-Associated)，Epidermal-Type Fatty Acid-Binding Protein，Fatty Acid-Binding Protein 5，KFABP，Fatty Acid-Binding Protein， Epidermal，PAFABP，EFABP，FABP5
Background
Fatty acid-binding protein 5 (FABP5), is also known as Fatty acid-binding protein, epidermal (E-FABP), Psoriasis-associated fatty acid-binding protein homolog (PA-FABP). FABP5 / E-FABP belongs to the calycin superfamily and fatty-acid binding protein (FABP) family. FABP5 / E-FABP is highly expressed in psoriatic skin. FABP5 / E-FABP has high specificity for fatty acids and has highest affinity for C18 chain length. FABP5 may be involved in keratinocyte differentiation.
FABP5 Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| ART-2612 | ART-2612; ART 26.12; ART26.12 | Phase 1 Clinical | Stony Brook University, The Research Foundation of the State University of New York | Anxiety; Breast Neoplasms; Neoplasms; Pain; Peripheral Nervous System Diseases; Prostatic Neoplasms | Details |